Mutations in the extracellular domain cause RET loss of function by a dominant negative mechanism

Molecular and Cellular Biology

Volumn 18, Issue 6, 1998, Pages 3321-3329

  Cosma, Maria Pia ^a   Cardone, Monica ^a   Carlomagno, Francesca ^b   Colantuoni, Vittorio ^a,b,c  

^a CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; TYROSINE KINASE RECEPTOR;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GENE MUTATION; GENETIC TRANSFECTION; HIRSCHSPRUNG DISEASE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; NONHUMAN; ONCOGENE RET; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; SIPPLE SYNDROME; TRANSACTIVATION;

ANIMALIA;

EID: 0031843172     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.6.3321     Document Type: Article

References (40)

1. Angrist, M., S. Bolk, B. Thiel, E. G. Puffemberger, R. M. W. Hofstra, C. H. C. M. Buys, D. T. Cass, and A. Chakravarti. 1995. Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease. Hum. Mol. Genet. 4:821-830.
2. Asai, N., T. Iwashita, M. Matsuyama, and M. Takahashi. 1995. Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol. Cell. Biol. 15:1613-1619.
3. Avantaggiato, V., N. A. Dathan, M. Grieco, N. Fabien, D. Lazzaro, A. Fusco, A. Simeone, and M. Santoro. 1994. Developmental expression of the RET proto-oncogene. Cell Growth Differ. 5:305-311.
4. Bongarzone, I., N. Monzini, M. G. Borrello, C. Carcano, G. Ferraresi, E. Arighi, P. Mondellini, G. Della Porta, and M. A. Pierotti. 1993. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RIα of cyclic AMP-dependent protein kinase A. Mol. Cell. Biol. 13:358-366.
5. Buj Bello, A., J. Adu, L. G. Pinon, A. Horton, J. Thompson, A. Rosenthal, M. Chinchetru, V. L. Buchman, and A. M. Davies. 1997. Neurturin responsiveness requires a GPI-linked receptor and the Ret receptor tyrosine kinase. Nature 387:721-724.
6. Carlomagno, F., G. De Vita, M. T. Berlingieri, V. de Franciscis, R. M. Melillo, V. Colantuoni, M. H. Kraus, P. P. Di Fiore, A. Fusco, and M. Santoro. 1996. Molecular heterogeneity of RET loss of function in Hirschsprung's disease. EMBO J. 15:2717-2725.
7. Collesi, C., M. Santoro, G. Gaudino, and P. Comoglio. 1996. A splicing variant of the RON transcript induces contitutive tyrosine kinase activity and an invasive phenotype. Mol. Cell. Biol. 16:5518-5526.
8. Cosma, M. P., L. Panariello, L. Quadro, N. A. Datan, O. Fattoruso, and V. Colantuoni. 1996. A mutation in the RET proto-oncogene in Hirschsprung's disease affects the tyrosine kinase activity associated with multiple endocrine neoplasia type 2A and 2B. Biochem. J. 314:397-400.
9. Coulier, F., R. Kumar, M. Ernst, R. Klein, D. Martin-Zanca, and M. Barbacid. 1990. Human trk oncogenes activated by point mutation, in-frame deletion, and duplication of the tyrosine kinase domain. Mol. Cell. Biol. 10:4202-4210.
10. Donis-Keller, H., S. Dou, D. Chi, K. M. Carlson, K. Toshima, T. C. Lairmore, J. R. Howe, P. Goodfellow, and S. A. Wells. 1993. Mutations in the RET proto-oncogene are associated with MEN2A and FMTC. Hum. Mol. Genet. 2:851-856.
11. Durbec, P., C. V. Marcos Gutierrez, C. Kilkenny, M. Grigoriou, K. Wartiowaara, P. Suvanto, D. Smith, B. Ponder, F. Costantini, M. Saarma, H. Sariola, and V. Pachnis. 1996. GDNF signalling through the Ret receptor tyrosine kinase. Nature 381:789-793.
12. Edery, P., S. Lyonnet, L. M. Mulligan, A. Pelet, E. Dow, L. Abel, S. Holder, C. Nihoul, B. A. J. Ponder, and A. Munnich. 1994. Mutations of the RET proto-oncogcne in Hirschsprung's disease. Nature 367:378-380.
13. Eng, C., and L. M. Mulligan. 1997. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease. Hum. Mutat. 9:97-109.
14. Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
15. Hofstra, R. M. W., R. M. Landsvater, I. Ceccherini, R. P. Stulp, T. Stelwagen, Y. Luo, B. Pasini, J. W. M. Hoppener, H. K. Ploos van Amstel, G. Romeo, C. J. M. Lips, and C. H. C. M. Buys. 1994. A mutation in the RET protooncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367:375-376.
16. Ikeda, I., Y. Ishizaka, T. Tahira, T. Suzuki, M. Onda, T. Sugimura, and M. Nagao. 1990. Specific expression of the RET proto-oncogene in human neuroblastoma cell lines. Oncogene 5:1291-1296.
17. Iwashita, T., H. Murakami, N. Asai, and M. Takahashi. 1996. Mechanism of Ret dysfunction by Hirschsprung mutations affecting its extracellular domain. Hum. Mol. Genet. 5:1577-1580.
18. Jing, S., D. Wen, Y. Yu, P. L. Holst, Y. Luo, M. Fang, R. Tamir, L. Antonio, Z. Hu, R. Cupples, J. C. Louis, S. Hu, B. W. Altrock, and G. M. Fox. 1996. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85:1113-1124.
19. Klein, R. D., D. Sherman, W. H. Ho, D. Stone, G. L. Bennett, B. Moffat, R. Vandlen, L. Simmons, Q. Gu, J. A. Hongo, B. Devaux, K. Poulsen, M. Armanini, C. Nozaki, N. Asai, A. Goddard, H. Phillips, C. E. Henderson, M. Takahashi, and A. Rosenthal. 1997. A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature 387:717-721.
20. Luo, Y., I. Ceccherini, B. Pasini, I. Matera, M. P. Bicocchi, V. Barone, R. Bocciardi, H. Kaariaiainen, D. Weber, M. Devoto, and G. Romeo. 1993. Close linkage with the RET proto-oncogene and boundaries of deletion mutants in autosomal dominant Hischsprung disease. Hum. Mol. Genet. 11:1803-1808.
21. Martucciello, G., M. P. Bicocchi, P. Dodero, M. Lerone, M. S. Cirillo, A. Puliti, G. Gimelli, G. Romeo, and V. Jasonni. 1992. Total colonic aganglionosis associated with interstitial deletion of the long arm of chromosome 10. Pediatr. Surg. Int. 7:308-310.
22. Mulligan, L. M., J. B. Kwok, C. S. Healey, M. J. Elsdon, C. Eng, E. Gardner, D. R. Love, S. E. Mole, and J. K. Moore. 1993. Germline mutations of the RET protooncogene in multiple endocrine neoplasia type 2A families. Nature 363:458-460.
23. Nakamura, T., Y. Ishizaka, M. Nagao, M. Hara, and T. Ishikawa. 1994. Expression of the ret proto-oncogene product in human normal and neoplastic tissues of neural crest origin. J. Pathol. 172:255-260.
24. Pachnis, V., B. Mankoo, and F. Costantini. 1993. Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119:1005-1017.
25. Pasini, B., M. G. Borrello, A. Greco, I. Bongarzone, Y. Luo, P. Mondellini, L. Alberti, C. Miranda, E. Arighi, R. Bocciardi, M. Seri, V. Barone, M. T. Radice, G. Romeo, and M. A. Pierotti. 1995. Loss of function effect of RET mutations causing Hirschsprung disease. Nat. Genet. 10:35-40.
26. Passarge, E. 1967. The genetics of Hirschsprung's disease. N. Engl. J. Med. 276:138-141.
27. Rodriguez, G. A., M. A. Naujokas, and M. Park. 1991. Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing. Mol. Cell. Biol. 11:2962-2970.
28. Romeo, G., P. Ronchetto, Y. Luo, V. Barone, M. Seri, I. Ceccherini, B. Pasini, R. Bocciardi, M. Lerone, H. Kaariainen, and G. Martucciello. 1994. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 367:377-378.
29. Sanchez, M. P., I. Silos Santiago, J. Frisen, B. He, S. A. Lira, and M. Barbacid. 1996. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382:70-73.
30. Santoro, M., R. Rosati, M. Grieco, M. T. Berlingieri, L. C. D'Amato, V. De Franciscis, and A. Fusco. 1990. The RET proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene 5:1595-1598.
31. Santoro, M., F. Carlomagno, A. Romano, D. P. Bottaro, N. A. Dathan, M. Grieco, A. Fusco, G. Vecchio, B. Matoskova, M. H. Kraus, and P. P. Di Fiore. 1995. Germ-line mutations of MEN2A and MEN2B activate RET as a dominant transforming gene by different molecular mechanisms. Science 267:381-383.
32. Schimke, R. N. 1984. Genetic aspects of multiple endocrine neoplasia. Annu. Rev. Med. 35:25-31.
33. Schuchardt, A., V. D'Agati, L. L. Blomberg, F. Costantini, and V. Pachnis. 1994. The c-ret receptor tyrosine kinase gene is required for the development of the kidney and enteric nervous system. Nature 367:380-383.
34. Songyang, Z., K. L. Carraway III, M. J. Eck, S. C. Harrison, R. Feldman, M. Mohammadi, J. Schlessinger, S. R. Hubbard, D. P. Smith, C. Eng, M. J. Lorenzo, B. A. J. Ponder, B. J. Mayer, and L. C. Cantley. 1995. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373:536-539.
35. Takahashi, M., Y. Buma, T. Iwamoto, Y. Inaguma, H. Ikeda, and H. Hiai. 1988. Cloning and expression of the ret protooncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene 3:571-578.
36. Takahashi, M., Y. Buma, and H. Hiai. 1989. Isolation of the ret proto-oncogene cDNA with an amino-terminal signal sequence. Oncogene 4:805-806.
37. Takahashi, M., N. Asai, T. Iwashita, T. Isomura, and K. Miyazaki. 1993. Characterization of the RET proto-oncogene products expressed in mouse L cells. Oncogene 6:297-301.
38. Treanor, J., L. Goodman, F. de Sauvage, D. M. Stone, K. T. Poulsen, C. D. Beck, C. Gray, M. P. Armanini, R. A. Pollock, F. Hefti, H. S. Phillips, A. Goddard, M. W. Moore, A. Buj-Bello, A. M. Davies, N. Asai, M. Takahashi, R. Vandlen, C. E. Henderson, and A. Rosenthal. 1996. Characterization of a multicomponent receptor for GDNF. Nature 382:80-83.
39. Trupp, M., E. Arenas, M. Fainzilber, A. S. Nilsson, B. A. Sieber, M. Grigoriou, C. Kilkenny, E. S. Grueso, V. Pachnis, U. Arumae, H. Sariola, M. Saarma, and C. F. Ibanez. 1996. Functional receptor for GDNF encoded by c-ret proto-oncogene. Nature 381:785-789.
40. Worby, C. A., Q. C. Vega, Y. Zhao, H. H. J. Chao, A. F. Seasholtz, and J. E. Dixon. 1996. Glial cell line-derived neurotrophic factor signals through the RET receptor and activates mitogen-activated protein kinase. J. Biol. Chem. 271:23619-23622.